Evommune, Inc. (EVMN)
25.71
-0.29
(-1.12%)
USD |
NYSE |
Mar 02, 16:00
26.07
+0.36
(+1.40%)
After-Hours: 20:00
Evommune Total Liabilities (Quarterly) : 267.68M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Moderna, Inc. | 3.688B |
| BillionToOne, Inc. | 147.62M |
| Nektar Therapeutics | 216.26M |
| CorMedix, Inc. | 376.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.54M |
| Shareholders Equity (Quarterly) | -183.14M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |